TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Xtacy Therapeutics ( (TSE:LOAN) ) has issued an announcement.
Pegasus Mercantile Inc. announced that it has missed the filing deadline for its audited annual financial statements for the year ended September 30, 2024, due to a change in directors and audit procedures following an increase in client base and M&A discussions. The company has obtained a Management Cease Trade Order to allow more time for filing, expecting to complete the process by March 31, 2025, while maintaining alternative information guidelines and limiting trading activities for specific executives.
More about Xtacy Therapeutics
Pegasus Mercantile Inc., formerly known as Xtacy Therapeutics Corp., is involved in the financial services sector, with its shares listed on the Canadian Securities Exchange, Frankfurt Stock Exchange, and OTC markets.
YTD Price Performance: 25.00%
Average Trading Volume: 117,535
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.41M
For a thorough assessment of LOAN stock, go to TipRanks’ Stock Analysis page.